| Literature DB >> 35693688 |
Subhadeep Gupta1, Atanu Biswas1, Atanu Chandra2, Biman Kanti Ray1, Arpan Dutta1, Alak Pandit1.
Abstract
Objectives: The objective of this study is to analyse detailed clinical presentations, imaging findings, and outcome in a series of 17 cases (n = 17) with neurological complications following acute varicella infection.Entities:
Keywords: Ataxia; Chickenpox; Guillain–Barré syndrome; encephalitis; myelopathy
Year: 2022 PMID: 35693688 PMCID: PMC9175418 DOI: 10.4103/aian.aian_270_21
Source DB: PubMed Journal: Ann Indian Acad Neurol ISSN: 0972-2327 Impact factor: 1.714
The demographic and clinical profile of the study subjects
| Age at presentation (years)/gender | Latency from rash (days) | Clinical diagnosis | Neuroimaging | CSF study | Others | Treatment | Outcome at 3 months |
|---|---|---|---|---|---|---|---|
| 23/Male | 16 | GB syndrome (MRS 4 at presentation) | MRI spine - normal | Albumino-cytological dissociation | NCS - AIDP | IV-IG | MRS 2 at discharge |
| 19/Male | 12 | GB syndrome (MRS 5 at presentation) | MRI spine - normal | Albumino-cytological dissociation | NCS - AMSAN | IV-IG | MRS 2 at discharge, required mechanical ventilation |
| 36/Male | 15 | GB syndrome (MRS 4 at presentation), external ophthalmoparesis, optic neuritis | MRI brain, orbit and spine - normal | Albumino-cytological dissociation | NCS - AIDP, HIV positive, CD4 count - 458 | IV-IG | MRS 2 at discharge |
| 28/Male | 14 | GB syndrome (MRS 3 at presentation) | MRI spine - normal | Albumino-cytological dissociation | NCS - AMSAN | IV-IG | MRS 2 at discharge |
| 21/Male | 21 | GB syndrome (MRS 4 at presentation) | MRI spine - normal | Albumino-cytological dissociation | NCS - AMSAN | IV-IG | MRS 2 at discharge |
| 22/Female | 9 | Right LMN facial nerve palsy | MRI brain - normal | Normal | None | Oral valacyclovir and prednisolone | House-Brackmann Facial Nerve Score 8 |
| 29/Male | 8 | Left LMN facial nerve palsy | MRI brain - normal | Normal | None | Oral valacyclovir and prednisolone | House-Brackmann Facial Nerve Score 7 |
| 32/Male | 11 | Right LMN facial nerve palsy | MRI brain - normal | Normal | None | Oral valacyclovir and prednisolone | House-Brackmann Facial Nerve Score 8 |
| 24/Male | 9 | Left LMN facial nerve palsy | MRI brain - normal | Normal | None | Oral valacyclovir and prednisolone | House--Brackmann Facial Nerve Score 4 |
| 39/Female | 21 | Dorsal myelopathy (MRS 4 at presentation) | MRI spine - normal [Figure 1; Panel c,d] | Albumino-cytological dissociation | Anti-aquaporin 4, anti-MOG - negative | IV methylprednisolone and plasmapheresis | MRS 2 at discharge |
| 21/Female | 16 | Dorsal myelopathy (MRS 4 at presentation) | MRI spine - normal | Normal | Anti-aquaporin-4, and anti-MOG antibody - negative | IV methylprednisolone | MRS 2 at discharge |
| 21/Male | 14 | Dorsal myelopathy | MRI brain with whole spine - normal | Normal | ANA, ENA profile, anti-aquaporin-4, anti-MOG - negative | IV methylprednisolone | MRS 2 |
| 25/Female | 28 | Cerebellar ataxia | MRI brain - normal | Normal | PET scan - negative | IV methylprednisolone | No improvement (MRS 4) |
| 20/Female | 38 | Cerebellar ataxia | MRI brain - normal | Normal | PET scan - negative, autoimmune encephalitis profile - negative | IV methylprednisolone and IV-IG | No improvement (MRS 4) |
| 9/Female | 14 | Right hemiparesis, focal seizure (MRS 5 at presentation) | MRI brain - left MCA territory infarct. MRA - left MCA narrowing [Figure 1; Panel a,b] | Cell count of 20 mm-3 and normal glucose and protein | ANA, ANCA, CRP - negative | Inj. acyclovir and Inj. levetiracetam | MRS 3 at discharge |
| 32 years/Female | 23 | ADEM | MRI brain - bilateral fluffy white matter opacity in brain and brainstem [Figure 1; Panel e,f] | Albumino-cytological dissociation, OCB - absent | ANA, ENA profile, anti-aquaporin-4, anti MOG - negative | IV methylprednisolone | MRS 3 |
| 6/Female | 14 | Known NMOSD on rituximab. Presented with encephalopathy, GTCS (MRS 5 at presentation) | MRI (previous) - demyelination in brain, cervical cord and bilateral optic nerve | Could not be done | None | Inj. acyclovir, Inj. meropenem, levetiracetam and midazolam | MRS 6 |
ADEM: Acute demyelinating encephalomyelitis, AIDP: acute inflammatory demyelinating polyneuropathy, AMSAN: acute motor sensory axonal neuropathy, ANA: antinuclear antibody, ANCA: antineutrophil cytoplasmic antibody, CRP: c-reactive protein, ENA: extractable nuclear antigen, GB syndrome: Guillain-Barré syndrome, IV: intravenous, IV-IG: intravenous immunoglobulin, LMN: lower motor neuron, MCA: middle cerebral artery, MOG: myelin oligodendrocyte glycoprotein, MRA: magnetic resonance angiography, MRI: magnetic resonance imaging, MRS: Modified Rankin Scale, NCS: nerve conduction study, NMOSD: neuromyelitis optica spectrum disorders, OCB: oligoclonal antibody, PET: positron emission tomography
The clinical profile and course of the Guillain-Barré syndrome patients
| NCS | Duration of hospital stay (days) | Ventilator requirement | Cranial nerve involvement | Autonomic involvement | MRC sum score on presentation | MRC sum score on day 14 | MRC sum score on day 28 | MRC sum score on day 42 | |
|---|---|---|---|---|---|---|---|---|---|
| Case 1 | AIDP | 18 | No | Yes | No | 26 | 32 | 51 | 52 |
| Case 2 | AMSAN | 31 | Yes | Yes | Yes | 8 | 14 | 23 | 32 |
| Case 3 | AIDP | 20 | No | No | Yes | 25 | 43 | 49 | 54 |
| Case 4 | AMSAN | 23 | No | No | No | 22 | 38 | 43 | 51 |
| Case 5 | AMSAN | 19 | No | No | No | 36 | 49 | 52 | 57 |
AIDP: Acute inflammatory demyelinating polyneuropathy, AMSAN: acute motor and sensory axonal neuropathy, MRC: medical research council, NCS: nerve conduction study
Figure 1Gradual improvement of middle cerebral artery calibre and distal flow in the magnetic resonance time of flight angiography imaging at presentation (Panel a) and 6 months later (Panel b) in a patient of post-varicella acute left middle cerebral artery territory infarct (Case 15); magnetic resonance T2-weighted image in sagittal (Panel c) and axial (Panel d) image showing no signal change in dorsal cord (Case 10); magnetic resonance T2-weighted brain image in axial section at centrum semiovale (Panel e) and basal ganglia level (Panel f) showing bilateral asymmetric fluffy white matter signal changes with involvement of corpus callosum (Case 16)